Get all your news in one place.
100's of premium titles.
One app.
Start reading
Birmingham Post
Birmingham Post
Business
Sion Barry

Leading Welsh life sciences company Diurnal in £48m takeover by US firm

One of Wales’ leading life sciences firms, Diurnal, is set to be acquired by a US firm in a £48.3m cash deal.

Subject to shareholder approval the Cardiff-based Alternative Investment Market-listed firm will be acquired by Neurocrine, a neuroscience-focused biopharmaceutical company, with sales of $1bn.

Diurnal, which is headquartered in Cardiff and employs 33, is a pharmaceutical group targeting patient needs in chronic endocrine (hormonal) diseases.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.